Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA583412
Max Phase: Preclinical
Molecular Formula: C23H19N3O4S
Molecular Weight: 433.49
Molecule Type: Small molecule
Associated Items:
ID: ALA583412
Max Phase: Preclinical
Molecular Formula: C23H19N3O4S
Molecular Weight: 433.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)c1ccccc1NS(=O)(=O)c1cccc(-c2cnn(Cc3ccccc3)c2)c1
Standard InChI: InChI=1S/C23H19N3O4S/c27-23(28)21-11-4-5-12-22(21)25-31(29,30)20-10-6-9-18(13-20)19-14-24-26(16-19)15-17-7-2-1-3-8-17/h1-14,16,25H,15H2,(H,27,28)
Standard InChI Key: PHQOBFYGHBBCBV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 433.49 | Molecular Weight (Monoisotopic): 433.1096 | AlogP: 4.10 | #Rotatable Bonds: 7 |
Polar Surface Area: 101.29 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.04 | CX Basic pKa: 1.68 | CX LogP: 3.92 | CX LogD: 0.69 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.46 | Np Likeness Score: -1.76 |
1. Yin Z, Chen YL, Kondreddi RR, Chan WL, Wang G, Ng RH, Lim JY, Lee WY, Jeyaraj DA, Niyomrattanakit P, Wen D, Chao A, Glickman JF, Voshol H, Mueller D, Spanka C, Dressler S, Nilar S, Vasudevan SG, Shi PY, Keller TH.. (2009) N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase., 52 (24): [PMID:20014868] [10.1021/jm901044z] |
2. Venkatesham A, Saudi M, Kaptein S, Neyts J, Rozenski J, Froeyen M, Van Aerschot A.. (2017) Aminopurine and aminoquinazoline scaffolds for development of potential dengue virus inhibitors., 126 [PMID:27750144] [10.1016/j.ejmech.2016.10.008] |
3. Nascimento IJDS, Santos-Júnior PFDS, Aquino TM, Araújo-Júnior JX, Silva-Júnior EFD.. (2021) Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors., 224 [PMID:34274831] [10.1016/j.ejmech.2021.113698] |
Source(1):